EGY reframes FY26 as a transition year built on margin quality and a new technology platform
In its Full Year Result FY26 investor presentation, Energy Technologies (ASX: EGY) positioned the financial year to 30 June 2026 as a deliberate transition and expansionary period, prioritising margin quality over volume. The Group reported revenue of $3.9m (FY25: $8.1m), a net loss after tax of $(12.4)m (FY25: $(11.0)m), and administrative expenses of $4.1m, down 8.9%.
Management framed the revenue decline as a by-product of exiting low-margin volume rather than lost market position. All figures presented are unaudited management accounts and remain subject to completion of the external audit.
When big ASX news breaks, our subscribers know first
FY26 financial results — the numbers behind a deliberate reset
Revenue fell 51.1% year-on-year, which the Group attributed to a changed offering and revenue profile, not lost market position. Bambach withdrew from legacy low-margin contract volume and re-based pricing to reflect copper volatility and the cost-to-serve.
The NPAT loss widened by $1.4m. According to the presentation, this principally reflects the higher financing cost of $1.4m, rather than any deterioration in underlying trading. Administrative expenses reduced by $0.4m, or 8.9%, delivered while the Group launched Cogenic’s technology development programme.
| A$m | FY26 | FY25 | Change | % |
|---|---|---|---|---|
| Revenue | 3.9 | 8.1 | (4.2) | (51.1%) |
| Administrative expenses | (4.1) | (4.5) | 0.4 | (8.9%) |
| Net profit / (loss) after tax | (12.4) | (11.0) | (1.4) | (12.7%) |
Figures are unaudited management accounts for the full year ended 30 June 2026 and remain subject to external audit. Key FY26 highlights outlined by management included:
-
Acquisition of the Maradin Laser Optical Engineering IP portfolio by Cogenic Limited
-
First Master License Agreement with Amalgamated Vision in North America
-
A placement for ~$2.5m completed
-
Completion of the restructure of the Bambach operations
Cogenic — one wearable platform replacing four devices
The presentation detailed Cogenic’s proprietary technology as a single lightweight wearable platform that consolidates four integrated capabilities: two-way communications, body-worn video, heads-up visual information, and electronic data delivery.
Traditionally, these functions require four separate devices, a radio with microphone and earpiece, a body-worn camera, a handheld tablet or mobile data terminal (MDT), and a separate data terminal. That equates to four batteries, four potential failure points, and occupied hands. Cogenic aims to deliver the same capabilities through one device, one battery, with the operator eyes-up and hands free.
Cogenic’s proprietary technology includes custom-manufactured MEMS chips, which management described as a core element of the platform’s defensibility.
The Maradin IP acquisition, completed in March 2026 for approximately $953,872 AUD across staggered payments, brought 14 global laser optical engineering patents into Cogenic alongside the full development team, giving EGY a prototype-ready platform without the capital burden of early-stage R&D.
Target markets beyond defence
Management outlined that Cogenic is targeting multiple operational environments where hands-free access to communications, information and data offers meaningful benefit:
-
Defence & dismounted operations
-
Government uniformed services
-
Police & law enforcement
-
Fire & rescue
-
Ambulance & EMS
-
Critical infrastructure field operations
Targeting several verticals broadens the addressable base beyond defence alone.
A scalable, capital-light manufacturing model
The operating model is designed to support commercial-scale production, with the majority of manufacturing undertaken externally on a mass-production basis. This is intended to provide capacity elasticity without balance-sheet-heavy capital investment. Proprietary technology is retained in-house, with a lean internal footprint focused on design, integration, firmware and qualification, and unit economics that are expected to improve as volume builds.
The addressable market opportunity — illustrative, not a forecast
Every figure in this section represents an illustrative management estimate prepared for market-sizing purposes only. These are assumptions, not forecasts, and are not a projection of Cogenic or EGY revenue.
Management sized the total addressable market (TAM) at ~US$42bn across approximately 72.5m personnel globally. The serviceable addressable market (SAM), covering allied markets including ANZ, Five Eyes, NATO and selected Indo-Pacific and Gulf regions, was estimated at ~US$14bn. The serviceable obtainable market (SOM), representing a five-year served opportunity at 0.5%–1.5% of SAM, was placed at US$70m–210m.
A recurring layer of software, data services and support at an indicative US$600 per device per annum implies a ~US$7.1bn annual recurring opportunity at full penetration. The allied-market beachhead was estimated at approximately 265,000 addressable personnel, a ~US$0.9bn hardware opportunity.
| Target segment | Global personnel | Penetration | ASP (USD) | Segment TAM |
|---|---|---|---|---|
| Defence — dismounted / frontline | ~27.0m | 15% | $4,000 | $16.2bn |
| Police & law enforcement | ~12.0m | 25% | $3,500 | $10.5bn |
| Fire & rescue (career) | ~5.0m | 30% | $3,500 | $5.3bn |
| Ambulance / EMS | ~5.0m | 30% | $3,000 | $4.5bn |
| Border, customs & corrections | ~3.5m | 25% | $3,500 | $3.1bn |
| Industrial & critical infrastructure | ~20.0m | 5% | $2,500 | $2.5bn |
| Total addressable market | ~72.5m | — | — | ~$42.1bn |
Illustrative management estimates only. Not a forecast or guidance. Actual outcomes may differ materially.
Why the market opportunity matters for investors
For readers less familiar with market-sizing terminology, the three measures describe progressively narrower slices of opportunity. TAM is the total possible market across all segments and regions. SAM is the portion realistically serviceable given allied-market focus. SOM is the slice the Group could realistically capture within five years.
Why does this matter? The recurring software and data layer offers annuity-style revenue potential that extends beyond one-off hardware sales, a distinction that can materially change the quality of future earnings if adoption scales. These figures remain assumptions rather than guidance.
The presentation framed a dual engine: a stabilised legacy cable business through Bambach, alongside high-margin technology optionality through Cogenic.
Bambach — restructure complete, order book rebuild ahead
Management noted the Bambach restructure concluded in FY26, with the FY27 focus turning to rebuilding the order book toward previous levels. Bambach is an established Australian copper wire and cable business supplying state government agencies and large ERP and infrastructure participants, characterised by long qualification cycles and durable, repeatable demand.
| Then | Now |
|---|---|
| Broad, low-margin contract book | Selective, margin-qualified order book |
| Fixed cost base carried through cycle | Right-sized cost base and footprint |
| Copper input volatility absorbed | Pricing mechanisms passing through input cost |
| Volume-led KPIs | Return-led financial metrics |
The FY27 focus for Bambach was set out as follows:
-
Rebuild volumes toward previous levels, only on work clearing the new financial hurdles
-
Deepen state government panel positions and long-cycle infrastructure supply agreements
-
Protect margin integrity through disciplined tendering and copper pass-through
-
Convert the qualified pipeline with existing ERP and infrastructure customers
-
Provide working capital for the deliverable manufacturing cycle, with results anticipated to flow through in Q3 FY27
Outlook — stabilise, commercialise, scale
Management outlined a three-horizon strategy as forward direction. Horizon 1 (Stabilise) covers the completed restructure, overheads down $0.4m, and return-led metrics at Bambach. Horizon 2 (Commercialise) targets Cogenic trials, evaluations and reference deployments across defence, uniformed services and first responders. Horizon 3 (Scale) anticipates external mass manufacture at volume, the recurring software and data layer, and allied-market expansion.
The Amalgamated Vision license agreement, signed in July 2026, targets active AFWERX and NASA programs and earns Cogenic a 5% royalty on gross sales, positioning the North American partnership as the first commercial proof point for the wearable platform’s defence credentials.
FY27 priorities detailed in the presentation include:
-
Advancing Cogenic from product development contracts and customer trials toward commercial delivery contracts for finished product
-
Finalising custom MEMS supply and qualification for volume manufacture
-
Rebuilding the Bambach order book to prior levels under the new financial metrics
-
Maintaining administrative cost discipline as the technology programme scales
-
Continuing disciplined funding and capital management to support commercialisation, extinguish debt and fund Bambach working capital
Key message from the FY26 presentation
“FY26 was a deliberate transition year.”
Taken together, the presentation set out a dual-track investment case: a stabilised copper cable business intended to fund optionality in a high-margin, IP-backed wearable technology platform. Investors should note that all figures remain unaudited, and the market-sizing estimates are illustrative rather than forecasts.
Ready to Explore the Investment Case Behind Cogenic’s Wearable Technology Platform?
Energy Technologies (ASX: EGY) is positioning Cogenic as a capital-light, IP-backed platform targeting a serviceable addressable market estimated at ~US$14bn across defence, law enforcement, and first-responder verticals — underpinned by a stabilised Bambach cable business designed to fund the transition.
Investors seeking a deeper understanding of EGY’s dual-track strategy and FY27 priorities can explore the full Energy Technologies investor centre for the latest company updates and project details.